Qi Deng
Clinical trials sponsored by Qi Deng, explained in plain language.
-
Game-changing CAR-T therapy made inside the body could slash costs and save lives
Disease control Not yet recruitingThis early-stage study tests a new approach to CAR-T cell therapy for people with relapsed or hard-to-treat B-cell leukemia and lymphoma. Instead of making the CAR-T cells in a lab, the treatment creates them inside the patient's body, which could lower costs and make therapy fas…
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New CAR-T therapy targets hard-to-treat blood cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called GPRC5D CAR-T cell therapy for people with plasma cell disorders (like multiple myeloma) that have come back or stopped responding to other treatments. About 18 participants will receive the therapy to see if it is safe and shrin…
Phase: EARLY_PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC